The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Lynch, Kate D; Keshav, Satish; Chapman, Roger W

Lynch, Kate D; Keshav, Satish; Chapman, Roger W.

Affiliation

Lynch KD; Translational Gastroenterology Unit, Nuffield Department of Medicine, Level 5, John Radcliffe Hospital, University of Oxford, Headley Way, Headington, Oxford, OX3 9DU UK.
Keshav S; Translational Gastroenterology Unit, Nuffield Department of Medicine, Level 5, John Radcliffe Hospital, University of Oxford, Headley Way, Headington, Oxford, OX3 9DU UK.
Chapman RW; Translational Gastroenterology Unit, Nuffield Department of Medicine, Level 5, John Radcliffe Hospital, University of Oxford, Headley Way, Headington, Oxford, OX3 9DU UK.

Curr Hepatol Rep ; 18(1): 115-126, 2019.

Article de En | MEDLINE | ID: mdl-31008013

Mots clés

Crohn's disease; Inflammatory bowel disease; Integrin alpha4beta7; Primary sclerosing cholangitis; TNF-α; Ulcerative colitis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials / Prognostic_studies Langue: En Journal: Curr Hepatol Rep Année: 2019 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google